The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

CAR-T cells to deliver engineered peptide antigens and reprogram antigen specific T cell responses against solid tumors.

Daniel  Lee

No Relationships to Disclose

Andy J  Minn

Honoraria - AstraZeneca; Merck; Pfizer; Takeda

Consulting or Advisory Role - H3 Biomedicine; Takeda

Research Funding - Merck

Patents, Royalties, Other Intellectual Property - Filed patent related to modified CAR T cells; Patents related to the IFN pathway

Travel, Accommodations, Expenses - AstraZeneca; Merck; Pfizer; Takeda

Lexus R  Johnson

Patents, Royalties, Other Intellectual Property - Filed patent related to modified CAR T cells